HEALTHCARE amp LIFE SCIENCES GROUP
2
1
2
OUR CLIENTS GEThellip Sector expertise We offer unrivaled knowledge of the healthcare and life sciences industries our clientsrsquo businesses and the sector-specific competitive pressures bearing down on them Sullivan amp Cromwellrsquos Healthcare and Life Sciences Group has negotiated complex transactions and resolved high-stakes disputes for almost three decades Today it possesses an unparalleled grasp of these sectors and a practical understanding of the commercial realities underlying them We position our clients to succeed through it all
The Firm represents international clients in the following healthcare sectors
Pharmaceuticals and Life Sciences Medtech Health Insurers Healthcare Services
Healthcare and life sciences clients have long turned to SampC for help succeeding in todayrsquos rapidly changing business environment Large and mid-size public and private throughout their lifecycles these companies rely on our multi-disciplinary global team to address their most complex legal and business challenges and reach their strategic goals
3
Legal expertise Clients come to us for the high-quality counsel and hands-on representation we offer across multiple legal specialties to successfully execute their most important deals and resolve critical disputes We can execute any type of transaction in any economic climate or geographic region Our experience in this sector includes
MampA Corporate finance Intellectual property Executive compensation Tax Real estate Restructuring Litigation criminal defense and investigations
An integrated global team Wersquore a core group of dedicated healthcare advisers across our 13 offices on four continents with a strong track record of the sectorrsquos most significant transactions and litigation matters supported by all the resources of an integrated global firm Wersquore grateful to our clients for trusting us with their future and wersquoll continue to help them position themselves for growth and success in this exciting and ever-changing industry
4
Headline Healthcare and Life Sciences Transactions
2016
2015Cyberonics $15 billion merger with Sorin
to create LivaNova
Aetna $13 billion SEC-registered offering of notes counsel to underwriters
Synageva $84 billion acquisition by Alexion
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury
Teva $405 billion acquisition of Allergan Generics
Ferrosan in defending patent infringement claims brought by
Baxter Healthcare before the US International Trade Commission
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant)
CONMED $265 million acquisition of SurgiQuest and $700 million secured credit facilities to finance the acquisition
Stemcentrx $98 billion acquisition by AbbVie
Bayer $66 billion acquisition of Monsanto and related $9 billion divestitures $57 billion
syndicated bridge loan in connection with the acquisition counsel to the borrowermdash
the largest bridge loan in 2016 and in regulatory inquiries and congressional
testimony related to the mergerImpax Laboratories $586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Stryker in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement casesPhilips acquisition of Wellcentive
Stryker $28 billion acquisition of Sage Products from Madison Dearborn
Dyax $59 billion acquisition by Shire
CVS $127 billion acquisition of Omnicare
Bausch Health (formerly Valeant) $158 billion acquisition of Salix
AbbVie $55 billion proposed acquisition of Shire later terminated
UnitedHealth pharmacy care business OptumRxrsquos $128 billion combination with Catamaran
4
5
Headline Healthcare and Life Sciences Transactions
2018
2017Verily Life Sciences an Alphabet company
partnership with Temasek
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Praxair $80 billion merger of equals with Linde and in regulatory inquiries related to the merger
Micro Systems Engineering in obtaining a trial victory against Universal Instruments in a case alleging copyright trade secret and contractual claims
Syneos Health $74 billion merger of equals with inVentiv Health and in
financing matters
Philips acquisitions of Respiratory Technologies Electrical Geodesics and The
Spectranetics Corporation
Kite Pharma $119 billion acquisition by Gilead Sciences
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals AstraZeneca $2 billion SEC-registered
offering of notes counsel to the issuer
UnitedHealth in connection with Optumrsquos $43 billion acquisition of DaVita Medical Group
2019
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
Verily Life Sciences an Alphabet company $1 billion investment round
led by Silver Lake
Syntimmune Apple Tree Partners as the majority shareholder in Syntimmune
in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
CONMED $365 million acquisition of Buffalo Filter
Merck KGaA $64 billion acquisition of Versum Materials
Amgen $167 million acquisition of Nuevolution
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
Seattle Genetics $614 million acquisition of Cascadian Therapeutics
Genomic Health $28 billion combination with Exact Sciences
Novartis acquisition of The Medicines Company valuing the
company at approximately $97 billion
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
5
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
2
1
2
OUR CLIENTS GEThellip Sector expertise We offer unrivaled knowledge of the healthcare and life sciences industries our clientsrsquo businesses and the sector-specific competitive pressures bearing down on them Sullivan amp Cromwellrsquos Healthcare and Life Sciences Group has negotiated complex transactions and resolved high-stakes disputes for almost three decades Today it possesses an unparalleled grasp of these sectors and a practical understanding of the commercial realities underlying them We position our clients to succeed through it all
The Firm represents international clients in the following healthcare sectors
Pharmaceuticals and Life Sciences Medtech Health Insurers Healthcare Services
Healthcare and life sciences clients have long turned to SampC for help succeeding in todayrsquos rapidly changing business environment Large and mid-size public and private throughout their lifecycles these companies rely on our multi-disciplinary global team to address their most complex legal and business challenges and reach their strategic goals
3
Legal expertise Clients come to us for the high-quality counsel and hands-on representation we offer across multiple legal specialties to successfully execute their most important deals and resolve critical disputes We can execute any type of transaction in any economic climate or geographic region Our experience in this sector includes
MampA Corporate finance Intellectual property Executive compensation Tax Real estate Restructuring Litigation criminal defense and investigations
An integrated global team Wersquore a core group of dedicated healthcare advisers across our 13 offices on four continents with a strong track record of the sectorrsquos most significant transactions and litigation matters supported by all the resources of an integrated global firm Wersquore grateful to our clients for trusting us with their future and wersquoll continue to help them position themselves for growth and success in this exciting and ever-changing industry
4
Headline Healthcare and Life Sciences Transactions
2016
2015Cyberonics $15 billion merger with Sorin
to create LivaNova
Aetna $13 billion SEC-registered offering of notes counsel to underwriters
Synageva $84 billion acquisition by Alexion
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury
Teva $405 billion acquisition of Allergan Generics
Ferrosan in defending patent infringement claims brought by
Baxter Healthcare before the US International Trade Commission
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant)
CONMED $265 million acquisition of SurgiQuest and $700 million secured credit facilities to finance the acquisition
Stemcentrx $98 billion acquisition by AbbVie
Bayer $66 billion acquisition of Monsanto and related $9 billion divestitures $57 billion
syndicated bridge loan in connection with the acquisition counsel to the borrowermdash
the largest bridge loan in 2016 and in regulatory inquiries and congressional
testimony related to the mergerImpax Laboratories $586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Stryker in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement casesPhilips acquisition of Wellcentive
Stryker $28 billion acquisition of Sage Products from Madison Dearborn
Dyax $59 billion acquisition by Shire
CVS $127 billion acquisition of Omnicare
Bausch Health (formerly Valeant) $158 billion acquisition of Salix
AbbVie $55 billion proposed acquisition of Shire later terminated
UnitedHealth pharmacy care business OptumRxrsquos $128 billion combination with Catamaran
4
5
Headline Healthcare and Life Sciences Transactions
2018
2017Verily Life Sciences an Alphabet company
partnership with Temasek
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Praxair $80 billion merger of equals with Linde and in regulatory inquiries related to the merger
Micro Systems Engineering in obtaining a trial victory against Universal Instruments in a case alleging copyright trade secret and contractual claims
Syneos Health $74 billion merger of equals with inVentiv Health and in
financing matters
Philips acquisitions of Respiratory Technologies Electrical Geodesics and The
Spectranetics Corporation
Kite Pharma $119 billion acquisition by Gilead Sciences
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals AstraZeneca $2 billion SEC-registered
offering of notes counsel to the issuer
UnitedHealth in connection with Optumrsquos $43 billion acquisition of DaVita Medical Group
2019
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
Verily Life Sciences an Alphabet company $1 billion investment round
led by Silver Lake
Syntimmune Apple Tree Partners as the majority shareholder in Syntimmune
in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
CONMED $365 million acquisition of Buffalo Filter
Merck KGaA $64 billion acquisition of Versum Materials
Amgen $167 million acquisition of Nuevolution
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
Seattle Genetics $614 million acquisition of Cascadian Therapeutics
Genomic Health $28 billion combination with Exact Sciences
Novartis acquisition of The Medicines Company valuing the
company at approximately $97 billion
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
5
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
1
2
OUR CLIENTS GEThellip Sector expertise We offer unrivaled knowledge of the healthcare and life sciences industries our clientsrsquo businesses and the sector-specific competitive pressures bearing down on them Sullivan amp Cromwellrsquos Healthcare and Life Sciences Group has negotiated complex transactions and resolved high-stakes disputes for almost three decades Today it possesses an unparalleled grasp of these sectors and a practical understanding of the commercial realities underlying them We position our clients to succeed through it all
The Firm represents international clients in the following healthcare sectors
Pharmaceuticals and Life Sciences Medtech Health Insurers Healthcare Services
Healthcare and life sciences clients have long turned to SampC for help succeeding in todayrsquos rapidly changing business environment Large and mid-size public and private throughout their lifecycles these companies rely on our multi-disciplinary global team to address their most complex legal and business challenges and reach their strategic goals
3
Legal expertise Clients come to us for the high-quality counsel and hands-on representation we offer across multiple legal specialties to successfully execute their most important deals and resolve critical disputes We can execute any type of transaction in any economic climate or geographic region Our experience in this sector includes
MampA Corporate finance Intellectual property Executive compensation Tax Real estate Restructuring Litigation criminal defense and investigations
An integrated global team Wersquore a core group of dedicated healthcare advisers across our 13 offices on four continents with a strong track record of the sectorrsquos most significant transactions and litigation matters supported by all the resources of an integrated global firm Wersquore grateful to our clients for trusting us with their future and wersquoll continue to help them position themselves for growth and success in this exciting and ever-changing industry
4
Headline Healthcare and Life Sciences Transactions
2016
2015Cyberonics $15 billion merger with Sorin
to create LivaNova
Aetna $13 billion SEC-registered offering of notes counsel to underwriters
Synageva $84 billion acquisition by Alexion
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury
Teva $405 billion acquisition of Allergan Generics
Ferrosan in defending patent infringement claims brought by
Baxter Healthcare before the US International Trade Commission
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant)
CONMED $265 million acquisition of SurgiQuest and $700 million secured credit facilities to finance the acquisition
Stemcentrx $98 billion acquisition by AbbVie
Bayer $66 billion acquisition of Monsanto and related $9 billion divestitures $57 billion
syndicated bridge loan in connection with the acquisition counsel to the borrowermdash
the largest bridge loan in 2016 and in regulatory inquiries and congressional
testimony related to the mergerImpax Laboratories $586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Stryker in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement casesPhilips acquisition of Wellcentive
Stryker $28 billion acquisition of Sage Products from Madison Dearborn
Dyax $59 billion acquisition by Shire
CVS $127 billion acquisition of Omnicare
Bausch Health (formerly Valeant) $158 billion acquisition of Salix
AbbVie $55 billion proposed acquisition of Shire later terminated
UnitedHealth pharmacy care business OptumRxrsquos $128 billion combination with Catamaran
4
5
Headline Healthcare and Life Sciences Transactions
2018
2017Verily Life Sciences an Alphabet company
partnership with Temasek
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Praxair $80 billion merger of equals with Linde and in regulatory inquiries related to the merger
Micro Systems Engineering in obtaining a trial victory against Universal Instruments in a case alleging copyright trade secret and contractual claims
Syneos Health $74 billion merger of equals with inVentiv Health and in
financing matters
Philips acquisitions of Respiratory Technologies Electrical Geodesics and The
Spectranetics Corporation
Kite Pharma $119 billion acquisition by Gilead Sciences
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals AstraZeneca $2 billion SEC-registered
offering of notes counsel to the issuer
UnitedHealth in connection with Optumrsquos $43 billion acquisition of DaVita Medical Group
2019
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
Verily Life Sciences an Alphabet company $1 billion investment round
led by Silver Lake
Syntimmune Apple Tree Partners as the majority shareholder in Syntimmune
in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
CONMED $365 million acquisition of Buffalo Filter
Merck KGaA $64 billion acquisition of Versum Materials
Amgen $167 million acquisition of Nuevolution
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
Seattle Genetics $614 million acquisition of Cascadian Therapeutics
Genomic Health $28 billion combination with Exact Sciences
Novartis acquisition of The Medicines Company valuing the
company at approximately $97 billion
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
5
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
2
OUR CLIENTS GEThellip Sector expertise We offer unrivaled knowledge of the healthcare and life sciences industries our clientsrsquo businesses and the sector-specific competitive pressures bearing down on them Sullivan amp Cromwellrsquos Healthcare and Life Sciences Group has negotiated complex transactions and resolved high-stakes disputes for almost three decades Today it possesses an unparalleled grasp of these sectors and a practical understanding of the commercial realities underlying them We position our clients to succeed through it all
The Firm represents international clients in the following healthcare sectors
Pharmaceuticals and Life Sciences Medtech Health Insurers Healthcare Services
Healthcare and life sciences clients have long turned to SampC for help succeeding in todayrsquos rapidly changing business environment Large and mid-size public and private throughout their lifecycles these companies rely on our multi-disciplinary global team to address their most complex legal and business challenges and reach their strategic goals
3
Legal expertise Clients come to us for the high-quality counsel and hands-on representation we offer across multiple legal specialties to successfully execute their most important deals and resolve critical disputes We can execute any type of transaction in any economic climate or geographic region Our experience in this sector includes
MampA Corporate finance Intellectual property Executive compensation Tax Real estate Restructuring Litigation criminal defense and investigations
An integrated global team Wersquore a core group of dedicated healthcare advisers across our 13 offices on four continents with a strong track record of the sectorrsquos most significant transactions and litigation matters supported by all the resources of an integrated global firm Wersquore grateful to our clients for trusting us with their future and wersquoll continue to help them position themselves for growth and success in this exciting and ever-changing industry
4
Headline Healthcare and Life Sciences Transactions
2016
2015Cyberonics $15 billion merger with Sorin
to create LivaNova
Aetna $13 billion SEC-registered offering of notes counsel to underwriters
Synageva $84 billion acquisition by Alexion
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury
Teva $405 billion acquisition of Allergan Generics
Ferrosan in defending patent infringement claims brought by
Baxter Healthcare before the US International Trade Commission
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant)
CONMED $265 million acquisition of SurgiQuest and $700 million secured credit facilities to finance the acquisition
Stemcentrx $98 billion acquisition by AbbVie
Bayer $66 billion acquisition of Monsanto and related $9 billion divestitures $57 billion
syndicated bridge loan in connection with the acquisition counsel to the borrowermdash
the largest bridge loan in 2016 and in regulatory inquiries and congressional
testimony related to the mergerImpax Laboratories $586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Stryker in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement casesPhilips acquisition of Wellcentive
Stryker $28 billion acquisition of Sage Products from Madison Dearborn
Dyax $59 billion acquisition by Shire
CVS $127 billion acquisition of Omnicare
Bausch Health (formerly Valeant) $158 billion acquisition of Salix
AbbVie $55 billion proposed acquisition of Shire later terminated
UnitedHealth pharmacy care business OptumRxrsquos $128 billion combination with Catamaran
4
5
Headline Healthcare and Life Sciences Transactions
2018
2017Verily Life Sciences an Alphabet company
partnership with Temasek
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Praxair $80 billion merger of equals with Linde and in regulatory inquiries related to the merger
Micro Systems Engineering in obtaining a trial victory against Universal Instruments in a case alleging copyright trade secret and contractual claims
Syneos Health $74 billion merger of equals with inVentiv Health and in
financing matters
Philips acquisitions of Respiratory Technologies Electrical Geodesics and The
Spectranetics Corporation
Kite Pharma $119 billion acquisition by Gilead Sciences
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals AstraZeneca $2 billion SEC-registered
offering of notes counsel to the issuer
UnitedHealth in connection with Optumrsquos $43 billion acquisition of DaVita Medical Group
2019
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
Verily Life Sciences an Alphabet company $1 billion investment round
led by Silver Lake
Syntimmune Apple Tree Partners as the majority shareholder in Syntimmune
in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
CONMED $365 million acquisition of Buffalo Filter
Merck KGaA $64 billion acquisition of Versum Materials
Amgen $167 million acquisition of Nuevolution
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
Seattle Genetics $614 million acquisition of Cascadian Therapeutics
Genomic Health $28 billion combination with Exact Sciences
Novartis acquisition of The Medicines Company valuing the
company at approximately $97 billion
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
5
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
3
Legal expertise Clients come to us for the high-quality counsel and hands-on representation we offer across multiple legal specialties to successfully execute their most important deals and resolve critical disputes We can execute any type of transaction in any economic climate or geographic region Our experience in this sector includes
MampA Corporate finance Intellectual property Executive compensation Tax Real estate Restructuring Litigation criminal defense and investigations
An integrated global team Wersquore a core group of dedicated healthcare advisers across our 13 offices on four continents with a strong track record of the sectorrsquos most significant transactions and litigation matters supported by all the resources of an integrated global firm Wersquore grateful to our clients for trusting us with their future and wersquoll continue to help them position themselves for growth and success in this exciting and ever-changing industry
4
Headline Healthcare and Life Sciences Transactions
2016
2015Cyberonics $15 billion merger with Sorin
to create LivaNova
Aetna $13 billion SEC-registered offering of notes counsel to underwriters
Synageva $84 billion acquisition by Alexion
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury
Teva $405 billion acquisition of Allergan Generics
Ferrosan in defending patent infringement claims brought by
Baxter Healthcare before the US International Trade Commission
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant)
CONMED $265 million acquisition of SurgiQuest and $700 million secured credit facilities to finance the acquisition
Stemcentrx $98 billion acquisition by AbbVie
Bayer $66 billion acquisition of Monsanto and related $9 billion divestitures $57 billion
syndicated bridge loan in connection with the acquisition counsel to the borrowermdash
the largest bridge loan in 2016 and in regulatory inquiries and congressional
testimony related to the mergerImpax Laboratories $586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Stryker in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement casesPhilips acquisition of Wellcentive
Stryker $28 billion acquisition of Sage Products from Madison Dearborn
Dyax $59 billion acquisition by Shire
CVS $127 billion acquisition of Omnicare
Bausch Health (formerly Valeant) $158 billion acquisition of Salix
AbbVie $55 billion proposed acquisition of Shire later terminated
UnitedHealth pharmacy care business OptumRxrsquos $128 billion combination with Catamaran
4
5
Headline Healthcare and Life Sciences Transactions
2018
2017Verily Life Sciences an Alphabet company
partnership with Temasek
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Praxair $80 billion merger of equals with Linde and in regulatory inquiries related to the merger
Micro Systems Engineering in obtaining a trial victory against Universal Instruments in a case alleging copyright trade secret and contractual claims
Syneos Health $74 billion merger of equals with inVentiv Health and in
financing matters
Philips acquisitions of Respiratory Technologies Electrical Geodesics and The
Spectranetics Corporation
Kite Pharma $119 billion acquisition by Gilead Sciences
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals AstraZeneca $2 billion SEC-registered
offering of notes counsel to the issuer
UnitedHealth in connection with Optumrsquos $43 billion acquisition of DaVita Medical Group
2019
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
Verily Life Sciences an Alphabet company $1 billion investment round
led by Silver Lake
Syntimmune Apple Tree Partners as the majority shareholder in Syntimmune
in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
CONMED $365 million acquisition of Buffalo Filter
Merck KGaA $64 billion acquisition of Versum Materials
Amgen $167 million acquisition of Nuevolution
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
Seattle Genetics $614 million acquisition of Cascadian Therapeutics
Genomic Health $28 billion combination with Exact Sciences
Novartis acquisition of The Medicines Company valuing the
company at approximately $97 billion
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
5
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
4
Headline Healthcare and Life Sciences Transactions
2016
2015Cyberonics $15 billion merger with Sorin
to create LivaNova
Aetna $13 billion SEC-registered offering of notes counsel to underwriters
Synageva $84 billion acquisition by Alexion
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury
Teva $405 billion acquisition of Allergan Generics
Ferrosan in defending patent infringement claims brought by
Baxter Healthcare before the US International Trade Commission
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant)
CONMED $265 million acquisition of SurgiQuest and $700 million secured credit facilities to finance the acquisition
Stemcentrx $98 billion acquisition by AbbVie
Bayer $66 billion acquisition of Monsanto and related $9 billion divestitures $57 billion
syndicated bridge loan in connection with the acquisition counsel to the borrowermdash
the largest bridge loan in 2016 and in regulatory inquiries and congressional
testimony related to the mergerImpax Laboratories $586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Stryker in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement casesPhilips acquisition of Wellcentive
Stryker $28 billion acquisition of Sage Products from Madison Dearborn
Dyax $59 billion acquisition by Shire
CVS $127 billion acquisition of Omnicare
Bausch Health (formerly Valeant) $158 billion acquisition of Salix
AbbVie $55 billion proposed acquisition of Shire later terminated
UnitedHealth pharmacy care business OptumRxrsquos $128 billion combination with Catamaran
4
5
Headline Healthcare and Life Sciences Transactions
2018
2017Verily Life Sciences an Alphabet company
partnership with Temasek
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Praxair $80 billion merger of equals with Linde and in regulatory inquiries related to the merger
Micro Systems Engineering in obtaining a trial victory against Universal Instruments in a case alleging copyright trade secret and contractual claims
Syneos Health $74 billion merger of equals with inVentiv Health and in
financing matters
Philips acquisitions of Respiratory Technologies Electrical Geodesics and The
Spectranetics Corporation
Kite Pharma $119 billion acquisition by Gilead Sciences
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals AstraZeneca $2 billion SEC-registered
offering of notes counsel to the issuer
UnitedHealth in connection with Optumrsquos $43 billion acquisition of DaVita Medical Group
2019
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
Verily Life Sciences an Alphabet company $1 billion investment round
led by Silver Lake
Syntimmune Apple Tree Partners as the majority shareholder in Syntimmune
in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
CONMED $365 million acquisition of Buffalo Filter
Merck KGaA $64 billion acquisition of Versum Materials
Amgen $167 million acquisition of Nuevolution
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
Seattle Genetics $614 million acquisition of Cascadian Therapeutics
Genomic Health $28 billion combination with Exact Sciences
Novartis acquisition of The Medicines Company valuing the
company at approximately $97 billion
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
5
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
5
Headline Healthcare and Life Sciences Transactions
2018
2017Verily Life Sciences an Alphabet company
partnership with Temasek
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Praxair $80 billion merger of equals with Linde and in regulatory inquiries related to the merger
Micro Systems Engineering in obtaining a trial victory against Universal Instruments in a case alleging copyright trade secret and contractual claims
Syneos Health $74 billion merger of equals with inVentiv Health and in
financing matters
Philips acquisitions of Respiratory Technologies Electrical Geodesics and The
Spectranetics Corporation
Kite Pharma $119 billion acquisition by Gilead Sciences
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals AstraZeneca $2 billion SEC-registered
offering of notes counsel to the issuer
UnitedHealth in connection with Optumrsquos $43 billion acquisition of DaVita Medical Group
2019
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
Verily Life Sciences an Alphabet company $1 billion investment round
led by Silver Lake
Syntimmune Apple Tree Partners as the majority shareholder in Syntimmune
in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
CONMED $365 million acquisition of Buffalo Filter
Merck KGaA $64 billion acquisition of Versum Materials
Amgen $167 million acquisition of Nuevolution
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
Seattle Genetics $614 million acquisition of Cascadian Therapeutics
Genomic Health $28 billion combination with Exact Sciences
Novartis acquisition of The Medicines Company valuing the
company at approximately $97 billion
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
5
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
6
AbbVie $55 billion acquisition of Shire (later withdrawn)
Alcon and its independent directors $504 billion multistage acquisition by Novartismdashfirst in Novartisrsquos purchase of Nestleacutersquos 77 interest in Alcon and then its subsequent acquisition of the remaining publicly held minority interest in the company
Amgen $134 billion acquisition of worldwide rights to Otezlareg (apremilast) from Celgene Corporation in connection with Celgenersquos merger with Bristol-Myers Squibb
$167 million acquisition of Nuevolution
modified Dutch auction tender offer for up to $10 billion in value of shares of its common stock
$105 billion acquisition of Onyx Pharmaceuticals including on more than $8 billion of related finance matters
AstraZeneca $2 billion SEC-registered offering of notes counsel to the issuer
$6 billion SEC-registered offering of notes counsel to the underwriters
Pharmaceuticals and Life Sciences
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
7
Bayer $69 billion sale of its Animal Health business to Elanco Animal Health
$66 billion acquisition of Monsanto and in regulatory inquiries and congressional testimony related to the merger
$57 billion syndicated bridge loan counsel to the borrower The largest bridge loan in 2016 and the third-largest bridge loan of all time Winner Loans Deal of the Year ndash IFLR Europe
$9 billion sale of selected crop science assets to BASF
$7 billion guaranteed bonds offering pursuant to Rule 144A Reg S 2014 counsel to the issuer
$142 billion acquisition of the consumer care business of Merck
BeiGene $903 million global SEC-registered offering and second primary listing on the Hong Kong Stock Exchange counsel to the selling shareholders
Biohaven $300 million registered offering of common shares counsel to the issuer
Concordia Healthcare $35 billion acquisition of Amdipharm Mercury Limited
$12 billion acquisition of Covis Pharma and Covis Injectables
$790 million unsecured high-yield note offering counsel to the issuer
Deerfield Management as senior secured lender DIP lender and plan sponsor in the Chapter 11 cases of Melinta Therapeutics
Deerfield Management and Athyrium Capital out of court restructuring of Pernix Therapeutics
Dermapharm euro3767 million ($4618 million) IPO pursuant to Rule 144AReg S and Frankfurt listing German and US counsel to the issuer
Dyax $59 billion acquisition by Shire
Impax Laboratories $55 billion merger with Amneal Pharmaceuticals
$586 million acquisition of generic products from Teva and affiliates of Allergan and $600 million of debt financing for its acquisition
Integra Lifesciences Corporation $3 billion of bank financing
Kite Pharma $119 billion acquisition by Gilead Sciences
Merck KGaA $64 billion acquisition of Versum Materials
Novartis acquisition of The Medicines Company valuing the company at approximately $97 billion
Novo Nordisk in an antitrust class action relating to alleged overcharges for Prandinreg in which a highly favorable settlement was obtained after SampC filed a motion to dismiss
Oaktree Capital Management secured term loan and warrents to Oxford Biomedica
PharmaSGP euro127 million IPO Germanyrsquos first Prime Standard IPO of 2020
Praxair $80 billion merger of equals with Linde
Seattle Genetics $614 million acquisition of Cascadian Therapeutics and related bridge financing
Stemcentrx $98 billion acquisition by AbbVie
Sprout Pharmaceuticals $1 billion acquisition by Bausch Health (formerly Valeant Pharmaceuticals)
Synageva $84 billion acquisition by Alexion Pharmaceuticals
Syntimmune Apple Tree Partners as majority shareholder in Syntimmune in connection with Syntimmunersquos acquisition by Alexion Pharmaceuticals for up to $12 billion
Takeda Pharmaceutical on US securities law $62 billion acquisition of Shire
Teva Pharmaceutical $405 billion acquisition of Allergan Generics
$505 billion withdrawn unsolicited acquisition of Mylan
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
8
Medtech
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
9
Becton Dickinson $9675 billion SEC-registered offering of notes
$225 billion SEC-registered offering of depositary shares
$78273 million offering of notes
$1066 billion SEC-registered offering of notes
$62 billion SEC-registered global notes offering counsel to underwriters
CONMED $365 million acquisition of Buffalo Filter and $265 million acquisition of SurgiQuest and its related $700 million secured credit facilities to finance the acquisition
Cyberonics in its $15 billion merger with Sorin to create LivaNova
Deerfield Management as senior secured creditor DIP lender and plan sponsor in the Chapter 11 cases of Endologix
Ferrosan in defending patent infringement claims brought by Baxter Healthcare before the US International Trade Commission After the trial concluded Ferrosan settled the matter for approximately the cost of further litigation
Micro Systems Engineering in obtaining a trial victory against Universal Instruments Corp in a case alleging copyright trade secret and contractual claims Following a six-day jury trial the court granted MSEIrsquos motion for judgment as a matter of law
Philips acquisition of the Healthcare Information Systems business of Carestream Health Inc
$2 billion acquisition of The Spectranetics Corporation
acquisition of Electrical Geodesics
acquisition of Respiratory Technologies
participation in a $45 million private placement by Corindus Vascular Robotics of its common stock
acquisition of Wellcentive
$1 billion acquisition of Volcano Corporation
$1191 billion offering of notes pursuant to Reg S
Philips Oral Healthcare in a putative class action suit brought against Philips Oral Healthcare alleging that certain Sonicare toothbrushes (made by Philips) suffer from a common and inherent defect that reduces their rate and cleaning efficacy over time
Siemens Healthineers euro42 billion ($52 billion) Rule 144AReg S IPO and Frankfurt Stock Exchange listing German and US counsel to the underwriters
Stryker Corporation $28 billion acquisition of Sage Products from Madison Dearborn
$764 million acquisition of Trauson Holdings
acquisition of Stanmore Implants Worldwide from SIW Holdings
in persuading the Supreme Court to set aside the Federal Circuitrsquos standard for enhanced damages in patent infringement cases The decision will significantly impact patent litigation by making it harder for willful infringers to escape paying higher damages
Verily Life Sciences an Alphabet company
joint venture with Santen Pharmaceutical Co
$1 billion investment round led by Silver Lake and including Ontario Teachersrsquo Pension Plan and other global investment management firms
partnership with Temasek
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
10
Health Insurer
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
11
Sullivan amp Cromwell continues to earn its renown throughout the world as a law firm with a broad transactional practice and a firm whose attorneys elegantly blend technical legal expertise with commercial sensibilityrdquo
IFLR1000
ldquo
Aetna $1 billion SEC-registered offering of notes
$13 billion SEC-registered offering of notes
Two $750 million SEC-registered senior notes offering counsel to underwriters
CVS $127 billion acquisition of Omnicare
$21 billion acquisition of Coram from Apria Healthcare Group
5050 joint venture with Cardinal Health
Medco Health Solutions $291 billion merger with Express Scripts
UnitedHealth $28 billion acquisition of Empresas Banmeacutedica
$49 billion acquisition of 90 of Amil Participaccedilotildees SA
acquisition of XLHealth Corp
In obtaining and defending on appeal dismissal of action on behalf of hedge funds seeking to accelerate $850 million of UnitedHealthrsquos notes
WellCare $12 billion SEC-registered senior notes offering
$300 million SEC-registered high-yield notes offering
$600 million SEC-registered high-yield notes offering counsel to the issuer
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
12
Healthcare Services
Theyrsquore among the best in pretty much everything Theyrsquore great responsive and timelyrdquo
CHAMBERS USAldquo
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
13
Ares Management managed fundsrsquo $145 billion strategic partnership with DuPage Medical Group
Four Seasons Health Care shareholders in connection with its debt restructuring
Genomic Health $28 billion combination with Exact Sciences
Grupo Auacutena Enfoca in connection with its portfolio company Grupo Auacutenarsquos acquisition of Grupo Empresarial Las Ameacutericas
LabCorp $61 billion acquisition of Covance
Optum $43 billion acquisition of DaVita Medical Group
Quality Care Properties agreement with HCR ManorCare to transition the ownership and leadership of HCR ManorCare including its skilled nursing assisted living hospice and homecare businesses to QCP (later withdrawn)
Syneos Health $74 billion merger of equals with inVentiv Health and in financing matters and related litigation
UnitedHealth its pharmacy care business OptumRxrsquos $128 billion combination with Catamaran Corporation
Universal Medical Financial amp Technical Advisory Services Company Limited $514 million offering of global shares and initial listing on the Hong Kong Stock Exchange
$447 million global offering of shares and listing on the Hong Kong Stock Exchange counsel to the underwriters
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
14
National Law Journal Healthcare Trailblazer 2020Frank Aquila
National Law Journal Healthcare Trailblazers 2019Keith PagnaniKrishna Veeraraghavan
Law360 Life Sciences Group of The Year 2014 2017
Law360 Life Sciences MVP Matt Hurd 2014 2015 2017 2018 2020Krishna Veeraraghavan 2015 2016Frank Aquila 2013
The American Lawyerrsquos Dealmaker of the YearMatt Hurd
Bayer acquisition of Monsanto 2017 Bayer acquisition of the consumer care business of Merck 2015
The American Lawyerrsquos Dealmaker of the Week Alison Ressler
Bausch Health (formerly Valeant) acquisition of Salix 2015
Keith Pagnani and Melissa Sawyer UnitedHealth subsidiary OptumRxrsquos combination with Catamaran 2015
Matt Hurd and Krishna Veeraraghavan Synageva BioPharma acquisition by Alexion Pharmaceuticals 2015
Joe Frumkin Teva acquisition of Allergan Generics 2015
Awards amp Accolades
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
15
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
16
Practice Contacts
Mehdi Ansari+1 212 558 4314 ansarimsullcromcom
Francis J Aquila +1 212 558 4048 aquilafsullcromcom
Matthew B Goodman+1 212 558 4995 goodmanmsullcromcom
Renata B Hesse +1 202 956 7575 hessersullcromcom
Steven L Holley +1 212 558 4737 holleyssullcromcom
Eric Krautheimer+1 310 712 6678 krautheimeresullcromcom
Nader A Mousavi +1 650 461 5660 mousavinsullcromcom
C O - H E A D S H E A LT H C A R E amp L I F E S C I E N C E S
Keith A Pagnani +1 212 558 4397 pagnaniksullcromcom
Matthew G Hurd+1 212 558 3122 hurdmsullcromcom
Rita-Anne OrsquoNeill +1 310 712 6698 oneillrsullcromcom
Sarah P Payne +1 650 461 5669 paynesasullcromcom
Alison S Ressler +1 310 712 6630 resslerasullcromcom
George J Sampas +1 212 558 4945 sampasgsullcromcom
Melissa Sawyer+1 212 558 4243 sawyermsullcromcom
Krishna Veeraraghavan +1 212 558 7931 veeraraghavanksullcromcom
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
17
Copyright copy2020 Sullivan amp Cromwell LLP | LG4690 (1020)Attorney Advertising Prior results do not guarantee a similar outcome
Experience these value-added services
SampC Online Resources
COVID-19 Resources To help our clients and the public navigate this challenging time we have prepared an ongoing series of SampC memos podcasts and webinars outlining and explaining legal and legislative developments We will continue to provide updates as events unfold
SampC Client Alerts Receive our analysis and alerts on breaking legal developments in your selected practice areas and industries
Legal Developments Affecting the Workplace To stay informed of litigation and regulatory developments that affect the workplace as they occur subscribe to our blog here
Tune in to SampC Critical Insights a podcast series bringing you perspectives on the latest developments in law business and policy
Track FCPA investigations and enforcement activity and monitor the compliance landscape on the Foreign Corrupt Practices Act Clearinghouse created in collaboration with Stanford Law School
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP
wwwsullcromcom
new york washington dc los angeles palo alto
london paris frankfurt brussels
tokyo hong kong beijing melbourne sydney
Sign up to receive SampC publications SCPublicationssullcromcom
sullcrom
Sullivan amp Cromwell LLP